These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22918191)

  • 1. Ophthalmic antihistamines and H1-H4 receptors.
    Wade L; Bielory L; Rudner S
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):510-6. PubMed ID: 22918191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis.
    Sharif NA; Xu SX; Yanni JM
    J Ocul Pharmacol Ther; 1996; 12(4):401-7. PubMed ID: 8951676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
    Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies.
    Sharif NA; Su SX; Yanni JM
    J Ocul Pharmacol; 1994; 10(4):653-64. PubMed ID: 7714409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
    Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine receptors and the conjunctiva.
    Bielory L; Ghafoor S
    Curr Opin Allergy Clin Immunol; 2005 Oct; 5(5):437-40. PubMed ID: 16131920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
    Sharif NA; Wiernas TK; Griffin BW; Davis TL
    Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
    Yates SL; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Tedford CE
    J Pharmacol Exp Ther; 1999 May; 289(2):1151-9. PubMed ID: 10215699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future antihistamines: histamine H3 and H4 receptor ligands.
    Yu F; Bonaventure P; Thurmond RL
    Adv Exp Med Biol; 2010; 709():125-40. PubMed ID: 21618893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of receptor affinities of ophthalmic and systemic agents in dry eye disease.
    Janeczko P; Norris MR; Bielory L
    Curr Opin Allergy Clin Immunol; 2021 Oct; 21(5):480-485. PubMed ID: 34387278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends.
    Ben-Eli H; Solomon A
    Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):411-416. PubMed ID: 30020258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
    Agut J; Sánchez JC; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells.
    Hofstra CL; Desai PJ; Thurmond RL; Fung-Leung WP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1212-21. PubMed ID: 12626656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H4 receptor antagonists: the new antihistamines?
    Fung-Leung WP; Thurmond RL; Ling P; Karlsson L
    Curr Opin Investig Drugs; 2004 Nov; 5(11):1174-83. PubMed ID: 15573868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine and migraine revisited: mechanisms and possible drug targets.
    Worm J; Falkenberg K; Olesen J
    J Headache Pain; 2019 Mar; 20(1):30. PubMed ID: 30909864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihistamines in rhinoconjunctivitis.
    Howarth P
    Clin Allergy Immunol; 2002; 17():179-220. PubMed ID: 12113217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
    Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
    Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular imaging of histamine receptors in the human brain].
    Tashiro M; Yanai K
    Brain Nerve; 2007 Mar; 59(3):221-31. PubMed ID: 17370648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.